1st Quarter - Amendment

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$440,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 21, 2008 $660,000 Replaced
1st Quarter - Amendment (this page) Apr 23, 2008 $440,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Issues related to Uranium Enrichment Manufacturing

Foreign entity interest: As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —

Copyright/Patent/Trademark CPT

HR. 1908, S. 1145 Patent Reform Act of 2007

Foreign entity interest: As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Health Issues HCR

General issues related to the healthcare industry; General issues regarding reimbursement and procurement for medical technology.

Foreign entity interest: As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues listed above

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS New cond't Assoc. Admin; OMB: LA, Rep. M. Bilirakis

Agriculture AGR

HR. 2419- Farm Bill Extension Act of 2007 - provisions related to durable medical equipment reimbursement and sales and marketing practices.

Foreign entity interest: As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —
WHITNEY GARDINER —

Bills named: H.R. 2419 (110th)

Medicare/Medicaid MMM

HR. 1424 Paul Wellstone Mental Health and Addiction Equity Act, Sec.105, provisions related to Medicaid Drug Rebate; HR. 3162 Children's Health and Medicare Protection Act of 2007; HR. 5605 Physician Payments Sunshine Act of 2008 S. 2029 Physician Payments Sunshine Act of 2007 S. 221 Transparency in Medicare Device Pricing Act. Issues related to updated physician payments oxygen provisions.

Foreign entity interest: As the parent, Covidien Ltd (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —
WHITNEY GARDINER —

Bills named: H.R. 5605 (110th), S. 221 (110th), H.R. 1424 (110th), H.R. 3162 (110th), S. 2029 (110th)

Pharmacy PHA

HR. 3140 Saving Our Community Pharmacies Act of 2007, provisions related to Average Manufacturing Price (AMP) Issues relating to pain drugs and ANDA applications; HR. 3610 Food and Drug Import of Safety Act 2007

Foreign entity interest: As the parent, Covidien Ltd. (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
SUSAN KATHLEEN BUNNING —
JONATHAN S COLLARD —
JOHN CHRISTOPHER KALAVRITINOS New cont'd. Assoc. Admin; OMB; LA Rep. M. Balirakis

Bills named: H.R. 3140 (110th), H.R. 3610 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.